Artwork for podcast Gastrointestinal Cancer Update
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
Episode 1 • 23rd February 2024 • Gastrointestinal Cancer Update • Dr. Neil Love
00:00:00 01:00:33

Share Episode

Shownotes

Dr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers.

Follow

Links

Chapters

Video

More from YouTube